“…Hunyady et 1991), brain slices (Quach et al, 1981;, acetylcholine (Koenig & Edwardson, 1994, and recells in culture (Taylor & Richelson, 1979;Brown et al, 1986; ferences therein) and noradrenaline (Leeb-Lunberg et al, 1987;Nakahata & Harden, 1987;Dillon-Carter & Chuang, 1989;Hausdorff et al, 1990). However, although there have been Cowlen et al, 1990;Smit et al, 1992;Bristow & 7amani, 1993; numerous studies of the mechanisms involved in the desensi- Dickenson & Hill, 1993;McCreath et al, 1994), a number of tization of responses to histamine at Hi-receptors in intestinal which have provided evidence for changes at the level of the smooth muscle (Barsoum & Gaddum, 1935;Cantoni & Eastreceptor (Brown et al, 1986;Nakahata & Harden, 1987;Hishinuma & Uchida, 1988;Cowlen et al, 1990;Horio et al, 1990b; Leurs et al, 1990;Dickenson & Hill, 1993) which will cross the cell membrane and bind to intracellular IkkW Joumal of Pharmacoloa (1995) 116, 2715-2723 sites and become concentrated in compartments with a low pH, have been noted some years ago (Maloteaux et al, 1983). We have attempted to avoid these difficulties by synthesizing a quaternary amine radioligand for the H1-receptor, [3H]-(+)-N-methyl-4-methyldiphenhydramine ([3H]-QMDP), which should bind only to sites on the plasma membrane (Treherne & Young, 1988a (Wallace & Young, 1983;Treherne & Young, 1988b), which should allow extensive washing of cells, and (b) the availability of non-penetrant and penetrant HI-receptor antagonists, which might be used to determine binding to plasma membrane HI-receptors and plasma membrane+ intracellularreceptors, respectively.…”